Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
Text
Wakix® (pitolisant) – Expanded indication
June 24, 2024 - Harmony Biosciences announced the FDA approval of Wakix (pitolisant), for the treatment of excessive daytime sleepiness (EDS) in pediatric patients 6 years of age and older with narcolepsy.
